These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37390030)

  • 21. Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer.
    Olson RE; Smith A; Huggett G; Good P; Dudley M; Hardy J
    Trials; 2022 Sep; 23(1):752. PubMed ID: 36064621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare practitioner perceptions on barriers impacting cannabis prescribing practices.
    Hachem Y; Abdallah SJ; Rueda S; Wiese JL; Mehra K; Rup J; Cowan J; Vigano A; Costiniuk CT
    BMC Complement Med Ther; 2022 Sep; 22(1):237. PubMed ID: 36076191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users.
    Pledger M; Martin G; Cumming J
    N Z Med J; 2016 Apr; 129(1433):25-36. PubMed ID: 27349158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Information-Seeking Behavior and Unmet Knowledge Needs of Older Medicinal Cannabis Consumers in Canada: A Qualitative Descriptive Study.
    Butler JI; Dahlke S; Devkota R; Shrestha S; Hunter KF; Toubiana M; Kalogirou MR; Law J; Scheuerman M
    Drugs Aging; 2023 May; 40(5):427-438. PubMed ID: 37147415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis Use for Medicinal Purposes among Canadian University Students.
    Smith JM; Mader J; Szeto ACH; Arria AM; Winters KC; Wilkes TCR
    Can J Psychiatry; 2019 May; 64(5):351-355. PubMed ID: 30602305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….
    Baron EP
    Headache; 2015 Jun; 55(6):885-916. PubMed ID: 26015168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional survey exploring the knowledge, experiences and attitudes of Australian pharmacists toward medicinal cannabis.
    Bawa Z; Saini B; McCartney D; Bedoya-Pérez M; McLachlan AJ; McGregor IS
    Int J Clin Pharm; 2023 Apr; 45(2):375-386. PubMed ID: 36446995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bioethical considerations in the physician-patient relationship for the use of medicinal cannabis in Peru].
    Carracedo S
    Rev Peru Med Exp Salud Publica; 2019; 36(2):334-340. PubMed ID: 31460649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge, attitudes, and prescribing patterns of cannabis and cannabinoid-containing medicines among European healthcare workers: a systematic literature review.
    Hordowicz M; Klimkiewicz A; Jarosz J; Wysocka M; Jastrzębska M
    Drug Alcohol Depend; 2021 Apr; 221():108652. PubMed ID: 33667785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the medical cannabis prescribing behaviours of French general practitioners.
    Barré T; Venturino H; Di Beo V; Carrieri P; Pelissier-Alicot AL
    Drug Alcohol Rev; 2023 Feb; 42(2):299-303. PubMed ID: 36196529
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessing progress with the implementation of the New Zealand Medicinal Cannabis Scheme.
    Withanarachchie V; Rychert M; Wilkins C
    N Z Med J; 2022 Jan; 135(1548):7-12. PubMed ID: 35728125
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians].
    Cremer-Schaeffer P; Knöss W; Broich K
    Schmerz; 2019 Oct; 33(5):378-383. PubMed ID: 31243538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NICE Guideline On Medicinal Cannabis: Keeping Pandora's Box Shut Tight?
    Case P
    Med Law Rev; 2020 May; 28(2):401-411. PubMed ID: 32016366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Education, Knowledge, and Practice Characteristics of Cannabis Physicians: A Survey of the Society of Cannabis Clinicians.
    Takakuwa KM; Mistretta A; Pazdernik VK; Sulak D
    Cannabis Cannabinoid Res; 2021; 6(1):58-65. PubMed ID: 33614953
    [No Abstract]   [Full Text] [Related]  

  • 35. [Medicinal cannabis and cannabis-based medication: an appeal to physicians, journalists, health insurances, and politicians for their responsible handling].
    Häuser W; Hoch E; Petzke F; Thomasius R; Radbruch L; Batra A; Sommer C; Havemann-Reinecke U
    Schmerz; 2019 Oct; 33(5):466-470. PubMed ID: 31478143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections: A qualitative study with general practitioners in Malta.
    Saliba-Gustafsson EA; Nyberg A; Borg MA; Rosales-Klintz S; Stålsby Lundborg C
    PLoS One; 2021; 16(2):e0246782. PubMed ID: 33571265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using theory to explore facilitators and barriers to delayed prescribing in Australia: a qualitative study using the Theoretical Domains Framework and the Behaviour Change Wheel.
    Sargent L; McCullough A; Del Mar C; Lowe J
    BMC Fam Pract; 2017 Feb; 18(1):20. PubMed ID: 28193174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived support for medical cannabis use among approved medical cannabis users in Canada.
    Leos-Toro C; Shiplo S; Hammond D
    Drug Alcohol Rev; 2018 Jul; 37(5):627-636. PubMed ID: 29873132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. So near yet so far: why won't the UK prescribe medical cannabis?
    Nutt D; Bazire S; Phillips LD; Schlag AK
    BMJ Open; 2020 Sep; 10(9):e038687. PubMed ID: 32958492
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.